MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 102 filers reported holding MAXCYTE INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $944,568 | -37.8% | 303,718 | -11.0% | 0.01% | -50.0% |
| Q2 2023 | $1,518,878 | -13.1% | 341,321 | -5.9% | 0.01% | -22.2% |
| Q1 2023 | $1,747,654 | -9.6% | 362,584 | -1.4% | 0.02% | -18.2% |
| Q4 2022 | $1,933,512 | -22.7% | 367,588 | -4.9% | 0.02% | -29.0% |
| Q3 2022 | $2,501,000 | +36.5% | 386,602 | -2.7% | 0.03% | +47.6% |
| Q2 2022 | $1,832,000 | -36.5% | 397,382 | -2.6% | 0.02% | -27.6% |
| Q1 2022 | $2,886,000 | -34.1% | 408,167 | -4.6% | 0.03% | -32.6% |
| Q4 2021 | $4,379,000 | -19.4% | 428,021 | -4.3% | 0.04% | -25.9% |
| Q3 2021 | $5,430,000 | – | 447,288 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,225,000 | $17,608,500 | 11.83% |
| Vitruvian Partners LLP | 5,043,356 | $27,536,724 | 5.80% |
| NORTH RUN CAPITAL, LP | 451,960 | $2,467,702 | 5.67% |
| Casdin Capital, LLC | 9,505,000 | $51,897,300 | 4.02% |
| RIVER GLOBAL INVESTORS LLP | 1,648,238 | $8,749 | 1.88% |
| Pier Capital, LLC | 1,074,164 | $5,864,935 | 0.96% |
| Montanaro Asset Management Ltd | 929,000 | $4,915,460 | 0.80% |
| First Light Asset Management, LLC | 1,365,343 | $7,454,773 | 0.69% |
| Stonepine Capital Management, LLC | 273,287 | $1,492,147 | 0.63% |
| Mudita Advisors LLP | 90,201 | $492,498 | 0.43% |